One aspect of disease in systemic sclerosis, however, is of particular importance during pregnancy: the development of scleroderma renal crisis. While effective medications are usually contraindicated during pregnancy due to risk of adverse fetal effects, they should be considered in this unusual and life-threatening circumstance. We strongly recommend use of angiotensin-converting enzyme inhibitor or angiotensin receptor blockade therapy to treat active scleroderma renal crisis in pregnancy,